Which has the lower trailing P/E, BIO or BMRN?

BIO has the lower trailing P/E: BIO trades at 46.04 and BMRN at 147.54. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIO or BMRN?

Over the past five years, BMRN grew revenue faster — BIO at a 0.29% CAGR versus BMRN at 12.19%.

Is BIO or BMRN more profitable?

BIO runs the higher net margin — BIO at 8.59% versus BMRN at 2.14%.

How have BIO and BMRN total returns compared?

Over the past 10 years, BIO delivered 8.86% and BMRN delivered -4.98% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs BioMarin Pharmaceutical Inc. (BMRN)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and BioMarin Pharmaceutical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$10.22B

$379.82HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

BMRN

BioMarin Pharmaceutical Inc.

$11.12B

$57.54HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BIO vs BMRN

growth of $100 · dividends reinvested · last 10y

BIO +134.8% (+8.9%/yr)BMRN -39.5% (-4.9%/yr)BIO compounded faster over this window

BIO BMRN

BIO vs BMRN: by the numbers

•BMRN is the larger company ($11.12B vs $10.22B market cap).
•BIO trades at the lower trailing earnings multiple (46.04 vs 147.54 P/E), one valuation lens rather than an overall verdict.
•BIO converts more revenue to profit (8.59% vs 2.14% net margin).
•BMRN grew revenue faster over the past five years (12.19% vs 0.29% CAGR).

Metrics side by side

Valuation

Metric	BIO	BMRN
P/E ratio	46.04	147.54
Forward P/E	38.96	N/A
P/S ratio	3.95	3.26
P/B ratio	1.43	1.76
EV / EBITDA	28.52	33.90
FCF yield	3.45%	6.59%

Profitability

Metric	BIO	BMRN
Gross margin	51.90%	75.55%
Operating margin	9.08%	16.56%
Net margin	8.59%	2.14%
ROE	3.10%	1.15%
ROIC	1.54%	1.40%

Growth (annualized)

Metric	BIO	BMRN
Revenue CAGR (5Y)	0.29%	12.19%
EPS CAGR (5Y)	-26.27%	-17.46%
FCF CAGR (5Y)	-9.65%	33.84%
Total return CAGR (5Y)	-12.10%	-5.59%

Frequently asked

Which has the lower trailing P/E, BIO or BMRN?: BIO has the lower trailing P/E: BIO trades at 46.04 and BMRN at 147.54. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIO or BMRN?: Over the past five years, BMRN grew revenue faster — BIO at a 0.29% CAGR versus BMRN at 12.19%.
Is BIO or BMRN more profitable?: BIO runs the higher net margin — BIO at 8.59% versus BMRN at 2.14%.
How have BIO and BMRN total returns compared?: Over the past 10 years, BIO delivered 8.86% and BMRN delivered -4.98% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full BMRN analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio BioMarin Pharmaceutical P/E ratio Bio-Rad Laboratories ROE BioMarin Pharmaceutical ROE Bio-Rad Laboratories operating margin BioMarin Pharmaceutical operating margin Bio-Rad Laboratories revenue growth BioMarin Pharmaceutical revenue growth Bio-Rad Laboratories free cash flow BioMarin Pharmaceutical free cash flow

Bio-Rad Laboratories & BioMarin Pharmaceutical appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.